1023 related articles for article (PubMed ID: 15946423)
21. GLP-1 and the long-term outcome of type 2 diabetes mellitus after Roux-en-Y gastric bypass surgery in morbidly obese subjects.
Jiménez A; Casamitjana R; Flores L; Delgado S; Lacy A; Vidal J
Ann Surg; 2013 May; 257(5):894-9. PubMed ID: 23579541
[TBL] [Abstract][Full Text] [Related]
22. Remission of type 2 diabetes after Roux-en-Y gastric bypass is associated with greater weight loss.
Kadera BE; Lum K; Grant J; Pryor AD; Portenier DD; DeMaria EJ
Surg Obes Relat Dis; 2009; 5(3):305-9. PubMed ID: 19460674
[TBL] [Abstract][Full Text] [Related]
23. The effects of duodenal-jejunal exclusion on hormonal regulation of glucose metabolism in Goto-Kakizaki rats.
Pacheco D; de Luis DA; Romero A; González Sagrado M; Conde R; Izaola O; Aller R; Delgado A
Am J Surg; 2007 Aug; 194(2):221-4. PubMed ID: 17618808
[TBL] [Abstract][Full Text] [Related]
24. Serum ghrelin levels in response to glucose load in obese subjects post-gastric bypass surgery.
Tritos NA; Mun E; Bertkau A; Grayson R; Maratos-Flier E; Goldfine A
Obes Res; 2003 Aug; 11(8):919-24. PubMed ID: 12917494
[TBL] [Abstract][Full Text] [Related]
25. Surgical approaches for the prevention and treatment of type 2 diabetes mellitus.
Coffin S; Konduru C; Schwarcz M; Frishman W
Cardiol Rev; 2009; 17(6):275-9. PubMed ID: 19829176
[TBL] [Abstract][Full Text] [Related]
26. Ileal transposition provides insight into the effectiveness of gastric bypass surgery.
Strader AD
Physiol Behav; 2006 Jun; 88(3):277-82. PubMed ID: 16782138
[TBL] [Abstract][Full Text] [Related]
27. Changes in glucagon-like peptide-1 (GLP-1) secretion after biliopancreatic diversion or vertical banded gastroplasty in obese subjects.
Valverde I; Puente J; Martín-Duce A; Molina L; Lozano O; Sancho V; Malaisse WJ; Villanueva-Peñacarrillo ML
Obes Surg; 2005 Mar; 15(3):387-97. PubMed ID: 15826475
[TBL] [Abstract][Full Text] [Related]
28. Calorie restriction is a major determinant of the short-term metabolic effects of gastric bypass surgery in obese type 2 diabetic patients.
Lips MA; de Groot GH; van Klinken JB; Aarts E; Berends FJ; Janssen IM; Van Ramshorst B; Van Wagensveld BA; Swank DJ; Van Dielen F; Willems van Dijk K; Pijl H
Clin Endocrinol (Oxf); 2014 Jun; 80(6):834-42. PubMed ID: 23711328
[TBL] [Abstract][Full Text] [Related]
29. Choosing an operation for weight control, and the transected banded gastric bypass.
Fobi MA; Lee H; Felahy B; Che K; Ako P; Fobi N
Obes Surg; 2005 Jan; 15(1):114-21. PubMed ID: 15760509
[TBL] [Abstract][Full Text] [Related]
30. Obesity surgery and the role in treating type 2 diabetes mellitus, are we ready for the next step?
Abbas SM
Curr Surg; 2006; 63(2):92-5; quiz 95-6. PubMed ID: 16520107
[No Abstract] [Full Text] [Related]
31. Molecular mechanisms of diabetes reversibility after bariatric surgery.
Rosa G; Mingrone G; Manco M; Euthine V; Gniuli D; Calvani R; Calvani M; Favuzzi AM; Castagneto M; Vidal H
Int J Obes (Lond); 2007 Sep; 31(9):1429-36. PubMed ID: 17515913
[TBL] [Abstract][Full Text] [Related]
32. Bariatric surgery: effects on glucose homeostasis.
Rubino F
Curr Opin Clin Nutr Metab Care; 2006 Jul; 9(4):497-507. PubMed ID: 16778583
[TBL] [Abstract][Full Text] [Related]
33. Bariatric surgery in obesity: changes of glucose and lipid metabolism correlate with changes of fat mass.
Frige' F; Laneri M; Veronelli A; Folli F; Paganelli M; Vedani P; Marchi M; Noe' D; Ventura P; Opocher E; Pontiroli AE
Nutr Metab Cardiovasc Dis; 2009 Mar; 19(3):198-204. PubMed ID: 18684601
[TBL] [Abstract][Full Text] [Related]
34. Differential loss of fat and lean mass in the morbidly obese after bariatric surgery.
Zalesin KC; Franklin BA; Lillystone MA; Shamoun T; Krause KR; Chengelis DL; Mucci SJ; Shaheen KW; McCullough PA
Metab Syndr Relat Disord; 2010 Feb; 8(1):15-20. PubMed ID: 19929598
[TBL] [Abstract][Full Text] [Related]
35. The state of the art in bariatric surgery for weight loss in the morbidly obese patient.
Hamad GG
Clin Plast Surg; 2004 Oct; 31(4):591-600, vi. PubMed ID: 15363912
[TBL] [Abstract][Full Text] [Related]
36. Peptide YY levels are elevated after gastric bypass surgery.
Chan JL; Mun EC; Stoyneva V; Mantzoros CS; Goldfine AB
Obesity (Silver Spring); 2006 Feb; 14(2):194-8. PubMed ID: 16571843
[TBL] [Abstract][Full Text] [Related]
37. Mechanisms of early improvement/resolution of type 2 diabetes after bariatric surgery.
Mingrone G; Castagneto-Gissey L
Diabetes Metab; 2009 Dec; 35(6 Pt 2):518-23. PubMed ID: 20152737
[TBL] [Abstract][Full Text] [Related]
38. Contribution of bariatric surgery to the comprehension of morbid obesity.
Marceau P
Obes Surg; 2005 Jan; 15(1):3-10. PubMed ID: 15760494
[TBL] [Abstract][Full Text] [Related]
39. Gastric banding for the treatment of type 2 diabetes mellitus in morbidly obese.
Brancatisano A; Wahlroos S; Matthews S; Brancatisano R
Surg Obes Relat Dis; 2008; 4(3):423-9. PubMed ID: 18226973
[TBL] [Abstract][Full Text] [Related]
40. Effect of bariatric surgery on liver glucose metabolism in morbidly obese diabetic and non-diabetic patients.
Immonen H; Hannukainen JC; Iozzo P; Soinio M; Salminen P; Saunavaara V; Borra R; Parkkola R; Mari A; Lehtimäki T; Pham T; Laine J; Kärjä V; Pihlajamäki J; Nelimarkka L; Nuutila P
J Hepatol; 2014 Feb; 60(2):377-83. PubMed ID: 24060855
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
